Eiken Chemical Co., Ltd.
EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention of epidemics. In 1949, we became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations. In addition to microbiological diagnosis, we have played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. In 1998, EIKEN CHEMICAL developed an innovative nucleic acid amplification method, definite “LAMP” (Loop-mediated Isothermal Amplification). With its advantages over conventional methods, it is inevitable that the LAMP method will be applied extensively across a variety of fields due to its outstanding characteristics as an innovative genetic testing procedure.
EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention of epidemics. In 1949, we became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations. In addition to microbiological diagnosis, we have played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. In 1998, EIKEN CHEMICAL developed an innovative nucleic acid amplification method, definite “LAMP” (Loop-mediated Isothermal Amplification). With its advantages over conventional methods, it is inevitable that the LAMP method will be applied extensively across a variety of fields due to its outstanding characteristics as an innovative genetic testing procedure.